The discovery that AMPK is the key downstream effector of the tumor suppressor LKB1 and the ability of AMPK to inhibit fatty acid synthesis, mRNA translation, and cell growth support the notion that this kinase acts as a tumor suppressor. This evidence concerns the gene PRKAA1 and neoplasm.